Tertiary hyperparathyroidism after long-term phosphate supplementation in adult-onset hypophosphataemic osteomalacia

British Journal of Rheumatology

Volumn 35, Issue 6, 1996, Pages 598-600

  Narvaez J ^a   Rodriguez Moreno, J ^a   Moragues, C ^a   Campoy, E ^a   Clavaguera, T ^a   Roig Escofet, D ^a  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

Author keywords

Hypophosphataemic osteomalacia; Long term phosphate therapy; Tertiary hyperparathyroidism

Indexed keywords

CALCITRIOL; PHOSPHATE; VITAMIN D;

ADULT; ARTICLE; CASE REPORT; DRUG MEGADOSE; HUMAN; HYPOPHOSPHATEMIA; LONG TERM CARE; MALE; OSTEOMALACIA; PRIORITY JOURNAL; SECONDARY HYPERPARATHYROIDISM;

CALCITRIOL; DRUG THERAPY, COMBINATION; HUMANS; HYPERPARATHYROIDISM; HYPOPHOSPHATEMIA; MALE; MIDDLE AGED; OSTEOMALACIA; PHOSPHATES; VITAMIN D;

EID: 0029935790     PISSN: 02637103     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Hahn TJ. Metabolic bone disease. In: Kelley WN, Harris ED, Ruddy S, Sledge CB, eds. Textbook of rheumatology, Vol. II. Philadelphia: WB Saunders, 1993:1593-627.
2. Favus MJ. Primer on the metabolic bone diseases and disorders of mineral metabolism. New York: Raven Press, 1993.
3. 3 on tubular handling of phosphate in hypophosphatemic rickets. J Clin Endocrinol Metab 1984;58:671-5.
4. Firth RG, Grant CS, Riggs BL. Development of hypercalcemic hyperparathyroidism after long-term phosphate supplementation in hypophosphatemic osteomalacia. Am J Med 1985;75:669-73.
5. Arnaud CD, Glorieux FH, Scriver C. Serum parathyroid hormone in X-linked hypophosphatemia. Science 1971;173:845-7.
6. Glorieux FH, Scriver CR, Reade TM, Goldman H, Roseborough A. Use of phosphate and vitamin D to prevent dwarfism and rickets in X-linked hypophosphatemia. N Engl J Med 1972;287:481-7.
7. Reitz RE, Weinstein RL. Parathyroid hormone secretion in familial vitamin D resistant rickets. N Engl J Med 1973;289:9415.
8. Glorieux FH, Marie PJ, Pettifor JM, Delvin EE. Bone response to phosphate salts, ergocalciferol, and calcitriol in hypophosphatemic vitamin D resistant rickets. N Engl J Med 1980;303:1023-31.
9. Rivkees SA, El-Hajj-Fuleihan G, Brown EM, Crawford JD. Tertiary hyperparathyroidism during high phosphate therapy of familial hypophosphatemic rickets. J Clin Endocrinol Metab 1992;75:1514-21.
10. Rasmussen H, Pechet M, Anast C, Mazur A, Gertner J, Broadus AE. Long-term treatment of familial hypophos- phatemic rickets with oral phosphate and calcitriol. J Pediatr 1981;99:16-25.
11. Bettinelli A, Bianchi ML, Mazazucchi E, Gandolini G, Appliani AC. Acute effects of calcitriol and phosphate salts on mineral metabolism in children with hypophosphatemic rickets. J Pediatr 1991;118:372-6.
12. Drezner MK, Lyles KW, Haussler MR, Harrelson JM. Evaluation of a role for 1-25-dihydroxyvitamin D in the pathogenesis and treatment of X-linked hypophosphatemic rickets and osteomalacia. J Clin Invest 1980;66:1020-5.
13. Verge CF, Lam AL, Simpson JM, Cowell CT, Howard NJ, Silink M. Effects of therapy in X-linked hypophosphatemic rickets. N Engl J Med 1991;325:1843-8.
14. Carpenter TO, Mitnick MA, Ellison A, Smith C, Insogna KL. Nocturnal hyperparathyroidism: a frequent feature of X-linked hypophosphatemia. J Clin Endocrinol Metab 1994;78:1378-83.
15. Kinder BK, Rasmussen H. New applications of total parathyroidectomy and autotransplantation. World J Surg 1985;9:156-64.